<DOC>
	<DOCNO>NCT01443689</DOCNO>
	<brief_summary>Burn trauma , especially extensive one , remain life-threatening local general inflammatory condition destroy skin underlie tissue , result serious sequela . Remarkable progress achieve last 30 yearsï¼Œstem cell therapy play important role progress . Human umbilical cord mesenchymal stem cell ( hUCMSCs ) human cord blood mononuclear cell ( hCBMNCs ) show ability modulate immune response enhance angiogenesis , suggest novel promising therapeutic strategy burn . In study , safety efficacy hUCMSCs hCBMNCs transplantation evaluate patient acute burn .</brief_summary>
	<brief_title>Allogenic Stem Cell Therapy Patients With Acute Burn</brief_title>
	<detailed_description>To investigate safety efficacy human cord blood mononuclear cell human umbilical cord mesenchymal stem cell transplantation patient Acute , Moderate-Severe , Full-thickness burn .</detailed_description>
	<mesh_term>Burns</mesh_term>
	<criteria>Between age 18 65 year , gender . Diagnosed Acute , ModerateSevere , fullthickness burn : Burn occur within 72 hour prior administration . TBSA 2055 % , third degree wound surface area &lt; 19 % ; Willing sign Informed Consent Form . All burn except thermal origin . Chronically malnourish , poor medical condition shock Systemic inflammatory response syndrome ( SIRS ) septicopyemia Moderatesevere inhalation injury airway lung HIV+ Autoimmune disease , e.g . lupus erythematosus , multiple sclerosis . Severe pulmonary hematological disease , malignancy hypoimmunity . Currently undertake treatment may affect safety/efficacy stem cell . Pregnancy lactation Enrollment trial last 3 month . Other criterion investigator consider improper inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Extensive Burn</keyword>
	<keyword>Human Cord Blood Mononuclear Cells</keyword>
	<keyword>Human Umbilical Cord Mesenchymal Stem Cells</keyword>
</DOC>